We revealed the susceptibility to levodopa-induced dyskinesia in patients with Parkinson’s disease to be associated with two NMDA receptor (GRIN2A) variants, identified by SNPs rs7192557 and rs8057394, which were previously found to be associated with the age of dyskinesia onset in Huntington’s disease [17]. Here, GRIN2A is linked to drug-induced dyskinesia.